Bill Baruch, president and founder of Blue Line Futures, previews E-mini S&P, Gold, Crude, and T...
ETFs for the ‘Worst Six Months’
04/14/2015 9:00 am EST
The end of the ‘Best Six Months’ is rapidly drawing near and the historically ‘Worst Six Months’ of May to October is approaching, explains market historian Jeffrey Hirsch in Stock Trader's Almanac Investor.
Due to the Fed’s zero interest rate policy (ZIRP), most money market accounts (and similar places to park cash during the ‘Worst Six Months’) pay literally nothing. This leaves few alternatives aside from the relative safety of Treasury bonds.
The problem here is longer-dated maturities offer the best yield, but also tend to be the most volatile. So any benefit of a higher yield can be quickly erased by a drop in bond price. To lessen volatility, shorter duration bonds are best, but here again, due to ZIRP, they also offer next to no yield.
The best approach would be to own Treasury bonds across the entire duration spectrum. By doing so, yield is likely to be more attractive and volatility could be trimmed.
iShares Core Total US Bond Market (AGG) nicely does just this. It holds Treasuries of multiple durations—yields right around 2%—and exhibits more price stability than other longer-dated Treasury bond ETFs.
Our next ETF to consider trading during the ‘Worst Six Months’ is iShares 20+ Year Treasury Bond (TLT). Its holdings are all long duration Treasury bonds and its current yield is right around 2.5%.
TLT offers a modest yield advantage over AGG, however; price movement is its real advantage (or disadvantage). Should the market unravel in a meaningful manner later this year, TLT could enjoy a rather robust rather.
For HDGE to be a homerun, the market needs to suffer a substantial breakdown in the ‘Worst Six Months.’ Even if the market moves sideways, HDGE’s rather lofty 2.92% net expense ratio is going to be a drag.
More than half of this fee is the cost of active management while short interest expense adds another 1.22%. HDGE can be considered on dips below $10.95.
More from MoneyShow.com:
Related Articles on MARKETS
Aurinia Pharmaceuticals (AUPH) is a clinical stage biopharmaceutical company focused on developing a...
As an old-fashioned burger joint that has a bit of a cult-like following, Shake Shack (SHAK) has alw...
Among higher-risk asset classes, these are cheaper this week: Dow, Eurozone Financials, US Banks, Hi...